Tweet
computer translated . . .
Waiting for Bird Flu Vaccine Made in Indonesia
By: Nur Ikhsan Suryakusumah
Technology - Tuesday, August 21, 2012 | 20:02 pm
[snip]
Through the Avian Influenza Unit-zoonotic Research Center-University of Airlangga (AIRC-Airlangga University), Surabaya, researchers began developing a bird flu vaccine since 2004. Dr. drh CA Nidom MS, molecular biologist Airlangga University, chairman of the bird flu vaccine research describes AIRC-UNAIR been around since 2004 coincided with the beginning of bird flu research.
In the course of time, from the University of Airlangga a State Owned Legal Entity (BHMN), then every unit on campus should produce a superior product.
"We developed the bioproduct development of influenza vaccines, including bird flu, with a variety of technologies. Includes developing diagnostic kits and rapid or conventional anti-viral of herbal medicine, "said Dr Nidom.
Moreover, the government supports the desire Unair create bird flu vaccine. Since then AIRC-UNAIR focus on making the bird flu vaccine for humans and animals.
Nidom then recruit fresh graduates from the Faculty of Pharmacy, Faculty of Medicine, Faculty of Veterinary Medicine, Faculty of Mathematics and Natural Sciences, Social-up communication.
They are in addition to earning scholarships untukpendidikan also advanced. The team has been accustomed to prioritize research culture. Thus, these researchers really focus.
Currently there are 10 employees working in the lab-UNAIR AIRC already taking courses S2 and S3 with an average age under 30 years.
To create a bird flu vaccine, the researchers had to sort out a virus that is in the field and then to stock the vaccine seed candidates in large quantities.
From the experiences of people with bird flu, who survived, was the case in Indonesia is a question of human-animal interface and must be prevented in many ways.
To develop the vaccine, AIRC-UNAIR collaboration with Institute Medical Science University of Tokyo, Hokkaido University, and the Influenza Research Center University of Wisconsin, Madison, USA.
Virus used for vaccine development from Indonesian patients, infected with bird flu and died in 2005. Nadom and timnnya take the virus from throat swabs from six different patient areas.
However, only viruses belonging patients aged 25-30 years and male sex can grow pretty well and made the master seed. . . .
Waiting for Bird Flu Vaccine Made in Indonesia
By: Nur Ikhsan Suryakusumah
Technology - Tuesday, August 21, 2012 | 20:02 pm
[snip]
Through the Avian Influenza Unit-zoonotic Research Center-University of Airlangga (AIRC-Airlangga University), Surabaya, researchers began developing a bird flu vaccine since 2004. Dr. drh CA Nidom MS, molecular biologist Airlangga University, chairman of the bird flu vaccine research describes AIRC-UNAIR been around since 2004 coincided with the beginning of bird flu research.
In the course of time, from the University of Airlangga a State Owned Legal Entity (BHMN), then every unit on campus should produce a superior product.
"We developed the bioproduct development of influenza vaccines, including bird flu, with a variety of technologies. Includes developing diagnostic kits and rapid or conventional anti-viral of herbal medicine, "said Dr Nidom.
Moreover, the government supports the desire Unair create bird flu vaccine. Since then AIRC-UNAIR focus on making the bird flu vaccine for humans and animals.
Nidom then recruit fresh graduates from the Faculty of Pharmacy, Faculty of Medicine, Faculty of Veterinary Medicine, Faculty of Mathematics and Natural Sciences, Social-up communication.
They are in addition to earning scholarships untukpendidikan also advanced. The team has been accustomed to prioritize research culture. Thus, these researchers really focus.
Currently there are 10 employees working in the lab-UNAIR AIRC already taking courses S2 and S3 with an average age under 30 years.
To create a bird flu vaccine, the researchers had to sort out a virus that is in the field and then to stock the vaccine seed candidates in large quantities.
From the experiences of people with bird flu, who survived, was the case in Indonesia is a question of human-animal interface and must be prevented in many ways.
To develop the vaccine, AIRC-UNAIR collaboration with Institute Medical Science University of Tokyo, Hokkaido University, and the Influenza Research Center University of Wisconsin, Madison, USA.
Virus used for vaccine development from Indonesian patients, infected with bird flu and died in 2005. Nadom and timnnya take the virus from throat swabs from six different patient areas.
However, only viruses belonging patients aged 25-30 years and male sex can grow pretty well and made the master seed. . . .
